Panacea Biotech Ltd., Novartis deal

Novartis said it and Panacea decided to amicably dissolve the 50-50 Indian JV Chiron Panacea Vaccines Pty. Ltd. for "strategic reasons." The JV was formed in 2004 to develop next-generative combinatio...